Australian (ASX) Pharmaceuticals & Biotech Dividend Stocks
UPDATED May 05, 2026
Discover Australian Pharmaceuticals & Biotech High Yield Dividend Stocks that are on the ASX and sorted by Dividend Yield. An upper limit of 20% is in place to filter out stocks with potentially unsustainable dividends. All companies with high dividend yields (above 5%) should be researched for sustainability. For more options please click on 'Advanced Filters'.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
VLS | AU$2.54 | -1.2% | 46.8% | AU$138.0m | n/a | 13.2 | n/a | 5.5% | ||
VIT | AU$0.039 | 5.4% | -44.3% | AU$25.8m | n/a | 33.0 | n/a | 5.1% | ||
CSL | AU$124.41 | -3.5% | -50.3% | AU$59.6b | AU$195.78 | 30.6 | 28.1% | 3.3% | ||
CUV | AU$9.55 | 4.6% | -15.5% | AU$481.6m | AU$23.20 | 14.8 | 24.9% | 0.5% | ||
CTE | AU$1.07 | 1.9% | 37.2% | AU$52.2m | n/a | 23.9 | n/a | 0% | ||
MVP | AU$0.46 | 3.4% | -26.6% | AU$51.3m | AU$2.03 | 1.3 | 80.0% | 0% | ||
ACR | AU$0.011 | -8.3% | -52.2% | AU$4.5m | n/a | 1.6 | n/a | 0% |
Page 1 of 1